Abstract
At present, treatment is aimed at preventing recurrent thrombosis, using aspirin (or clopidogrel (Plavix)), low molecular weight heparin or warfarin (Coumadin).
Despite reports of the use of newer ‘biological’ agents in some cases of Hughes syndrome, experience with agents such as rituximab, as well as with the newer anticoagulants such as dabigatran, is limited.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Hughes, G., Khamashta, M.A. (2013). Treatment. In: Hughes Syndrome: Highways and Byways. Springer, London. https://doi.org/10.1007/978-1-4471-5161-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5161-6_17
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5160-9
Online ISBN: 978-1-4471-5161-6
eBook Packages: MedicineMedicine (R0)